Discovery & Development Multiple internal therapeutic programs and proven proprietary platforms, Thrombotargets is an innovator in Drug Discovery and Development significantly improving the speed and efficiency of research and driving clinical trials to success HIT Screening by Lead Optimization...

Contact Us THROMBOTARGETS EUROPE Parc Mediterrani de la Tecnologia Av. Canal Olmpic, s/n Edif. B6, 2 planta 08860Castelldefels Espaa Telf:+34936642040 Fax: +34 93 635 07 12 Generalinfo@thrombotargets.com Inversiones inver@thrombotargets.com www.thrombotargets.com THROMBOTARGETS CORPORATION 2530 Meri...

Press Releases Press Releases Patents Press Releases DateNews & EventsLocation Previous News Upcoming Events DateNews & EventsLocation Previous Events Contact Us Site Map Privacy Terms of Use 2006 - Thrombotargets Corp. All rights reserved - Coagulation - Hemostatic ...

Corporate Thrombotargets approach to discovery and development enables drug candidates to advance rapidly through all clinical phases, therefore increasing the chances of a successful treatment reaching patients sooner Board of Scientific Advisors Board of Directors Executive Management Team Thrombo...

Discovery & Pipeline. Thrombotargets has developed and adapted to High Throughput Screening a new High Throughput Screening approach for the simultaneous quantifycation ofclot formation and clot lysis (Hemosta-BioPlatformScreen. With these proven proprietarynew HTS Platform,Thrombotargets is con...